DNAHC12 Inhibitors

DNAH12, predicted to have diverse functions including ATP binding, dynein intermediate chain binding, and dynein light intermediate chain binding activities, operates at the core of microtubule-based movement within the cilium and cytoplasm. These predicted functions underscore its integral role in cellular processes involving dynamic cytoskeletal rearrangements. Located within the dynein complex, DNAH12's involvement in microtubule-based movement, particularly within the cilium, emphasizes its significance in cellular motility and structural maintenance.

Inhibition of DNAH12 entails targeting its diverse functional domains and interactions within the dynein complex. Direct inhibitors, such as HPI-4 and CAY10618, disrupt dynein activity and dynein light intermediate chain binding, hindering DNAH12's function in microtubule-based movement and cilium function. Indirect inhibitors, including EHNA and Colchicine, modulate ATP binding or destabilize microtubules, impacting DNAH12's participation in these critical cellular processes. Additionally, small molecules like GW5074 and NG25 indirectly influence DNAH12 by modulating kinase activities, potentially affecting its role in microtubule dynamics. The microtubule-stabilizing agent Epothilone B and the myosin light chain kinase inhibitor ML7 offer further insights into potential strategies for regulating DNAH12 and its impact on cellular motility. Understanding these inhibitory mechanisms provides a comprehensive view of how DNAH12 orchestrates microtubule dynamics and cilium function, offering valuable insights into the intricate regulation of cellular motility and structural integrity.